BOSTON, Nov. 22 /PRNewswire/ -- Evidence Medical, a Delaware limited liability company and the exclusive licensee of seminal IT-related medical therapeutics and diagnostic patents from Advanced Biological Laboratories (Luxembourg), today announced that Virco BVBA (Mechelen, Belgium) has become the first commercial virology specialized diagnostic service provider to sublicense their patents. Financial and other terms were not disclosed.
Evidence Medical’s President, Gary Paul Magnant, stated of the agreement, “I am pleased that Virco is now a licensee. We expect other diagnostic companies will want to be licensed as well. At Evidence Medical we have long believed that the patents involved are seminal to the future of the therapeutic and diagnostic industries. They broadly cover the computer analysis of multiple databases which lead to a report meant to guide physicians towards the optimal therapy for a given patient. To date the patents have been principally discussed in context with HIV, but many other diseases are expected to require similar types of analysis and ranked reports in the near future.”
About Evidence Medical:
Evidence Medical holds exclusive license to certain US patents (US6,081,786 and US6,188,988) and their foreign equivalents. Evidence Medical is currently in the business of licensing intellectual property to diagnostic manufacturers, therapeutic companies, and diagnostic service providers.
Contact: Evidence Medical, LLC info@evidencemedical.comhttp://www.evidencemedical.com/
Evidence Medical, LLC
CONTACT: Evidence Medical, LLC, info@evidencemedical.com
Web site: http://www.evidencemedical.com/
